正文
Yan X, Ju H, Hou F, et al. Analysis of enhanced CT imaging signs and clinicopathological prognostic factors in hepatoid adenocarcinoma of stomach patients with radical surgery: a retrospective study[J]. BMC Med Imaging, 2023, 23(1):167. DOI: 10.1186/s12880-023-01125-z.
[7]
Chang MY, Kim HJ, Park SH, et al. CT features of hepatic metastases from hepatoid adenocarcinoma[J]. Abdom Radiol, 2017, 42(10): 2402-2409. DOI: 10.1007/s00261-017-1150-3.
[8]
Huang W, Li L, Li J, et al. Computed tomography features and clinical prognostic characteristics of hepatoid adenocarcinoma of the stomach[J]. Front Oncol, 2021, 11: 772636. DOI: 10.3389/fonc.2021.772636.
[9]
高虎云, 张永萍, 晏耀文, 等. 胃肝样腺癌伴肝脾转移误诊为晚期肝癌一例[J]. 中华肝脏病杂志, 2019, 27(9): 719-720. DOI: 10.3760/cma.j.issn.1007-3418.2019.09.013.
[10]
de Castria TB, Tang L, Queiroz MM, et al. Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report[J]. J Gastrointest Oncol, 2021, 12(6): 3123-3132. DOI: 10.21037/jgo-21-287.
[11]
赵丽娜, 袁静萍, 任家材, 等. 胃原发性肝样腺癌伴肝转移3例临床病理学分析[J]. 中华病理学杂志, 2022, 51(10): 1024-1026. DOI: 10.3760/cma.j.cn112151-20220726-00655.
[12]
李莉明, 黄文鹏, 赵慧萍, 等. 胃肝样腺癌CT及临床表现[J]. 中国医学影像技术, 2022, 38(5): 713-716. DOI: 10.13929/j.issn.1003-3289.2022.05.018.
[13]
林建贤, 王祖凯, 张鹏, 等. 胃肝样腺癌临床病理特征、预后及复发模式研究[J]. 中国实用外科杂志, 2022, 42(1): 69-79. DOI: 10.19538/j.cjps.issn1005-2208.2022.01.12.
[14]
梁子威, 李培杰, 赵葵, 等. 肝样腺癌的18F-FDG PET/CT及病理特征分析[J]. 中国医学装备, 2020, 17(12) : 52-55. DOI: 10.3969/J.ISSN.1672-8270.2020.12.013.
[15]
Ge D, Wang Y, Li Y, et al. Assessing clinical pathological characteristics and gene expression patterns associated with hepatoid adenocarcinoma of the stomach[J]. Clin Transl Oncol, 2024. DOI: 10.1007/s12094-024-03516-2.
[16]
刘畅, 毛国群, 杨光钊, 等. 肝样腺癌的临床特征及CT表现[J]. 实用放射学杂志, 2020, 36(11): 1781-1785. DOI: 10.3969/j.issn.1002-1671.2020.11.019.
[17]
Li L, Yang X, Ji W, et al. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study[J]. BMC Gastroenterol, 2023, 23(1): 142. DOI: 10.1186/ s12876-023-02773-9.
[18]
Zhao R, Li H, Ge W, et al. Comprehensive analysis of genomic alterations in hepatoid adenocarcinoma of the stomach and identification of clinically actionable alterations[J]. Cancers, 2022, 14(16): 3849. DOI: 10.3390/ cancers14163849.
[19]
Chen E, Wei Y, Liu H, et al. Hepatoid adenocarcinoma of stomach: emphasis on the clinical relationship with alpha-fetoprotein-positive gastric cancer[J]. Biomed Res Int, 2019, 2019: 6710428. DOI: 10.1155/2019/6710428.
[20]
成志锋, 吴延诲, 韩仕瑶, 等. 胃肝样腺癌1例并文献复习[J]. 腹部外科, 2023, 36(1): 76-79. DOI: 10.3969/j.issn. 1003-5591.2023.01.015.
[21]
刘晨旭. 胃肝样腺癌的临床病理特征及预后因素分析[D]. 郑州: 郑州大学, 2021.
[22]
Lin J, Wang Z, Hong Q, et al. Assessment of clinicopathological characteristics and development of an individualized prognostic model for patients with hepatoid adenocarcinoma of the stomach[J]. JAMA Netw Open, 2021, 4(10): e2128217. DOI: 10.1001/jamanetworkopen.2021. 28217.
[23]
Health China N. National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)[J]. Chin J Cancer Res, 2022, 34(3): 207-237. DOI: 10.21147/j.issn.1000-9604.2022.03.04.
[24]
Yang X, Wang A, Li J, et al. Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS)[J]. BMC Cancer, 2023, 23(1): 53. DOI: 10.1186/s12885-023-10516-y.
[25]
肖晓燕, 黄文鹏, 高剑波. 胃肝样腺癌的临床影像特征和预后研究进展[J]. 临床放射学杂志, 2022, 41(4): 785-788. DOI: 10.13437/j.cnki.jcr.2022.04.014.
[26]
蔡丰, 尚燕宁, 任安. 胃肝样腺癌的CT表现[J]. 中国医学影像学杂志, 2016, 24(5): 349-352. DOI: 10.3969/ j.issn.1005-5185.2016.05.008.
[27]
冯利波, 胡智斌, 彭林艳, 等. 胰腺肝样腺癌1例[J]. 中国医学影像学杂志, 2023, 31(9): 956-957. DOI: 10.3969/ j.issn.1005-5185.2023.09.011.
